These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Aplastic anaemia. I. Incidence and aetiology. Böttiger LE, Westerholm B. Acta Med Scand; 1972 Oct; 192(4):315-8. PubMed ID: 5081068 [No Abstract] [Full Text] [Related]
10. Drug-induced blood dyscrasias in Sweden. Böttiger LE, Westerholm B. Br Med J; 1973 Aug 11; 3(5875):339-43. PubMed ID: 4723818 [Abstract] [Full Text] [Related]
11. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part II. Chaplin S. Adverse Drug React Acute Poisoning Rev; 1986 Aug 11; 5(3):181-96. PubMed ID: 3538824 [No Abstract] [Full Text] [Related]
12. The sensitivity of human bone marrow granulocyte/monocyte precursor cells to phenylbutazone, oxyphenbutazone and gamma-hydroxyphenylbutazone in vitro, with observations on the bone marrow colony formation in phenylbutazone-induced granulocytopoenia. Smith CS, Chinn S, Watts RW. Biochem Pharmacol; 1977 May 01; 26(9):847-52. PubMed ID: 861050 [No Abstract] [Full Text] [Related]
15. Oxyphenbutazone (Tanderil) and blood dyscrasia. Brownlie BE, Strang PJ. N Z Med J; 1969 Feb 01; 69(441):77-9. PubMed ID: 5252205 [No Abstract] [Full Text] [Related]